MARCKSL1 and esophageal squamous cell carcinoma: Furthermore, it was demonstrated that ESCC patients with high expression levels (n = 220, IHC score >6) of MARCKSL1 had a worse survival rate than those with low expression levels (n = 464, IHC score ≤6) (p = 0.0222) by Kaplan–Meier survival analysis (Figure 5G).